CellProthera on regenerative medicine & global cardiac research

Emily Event News Leave a Comment

Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. Working on regenerative medicines to treat cardio diseases, CellProthera’s team aim to build a leading company in the field of regenerative medicine and put together every necessary effort to make …

Keynote speakers announced at BioPharma Asia Convention, Singapore

Emily Event News Leave a Comment

In case you have missed it, the BioPharma Asia 2017 is shaping up to be an exciting event this 21-23 March in Singapore. With over 140 speakers, more than 600 delegates and approximately 1500 attendees already confirmed, we are proud to share with you some of the prominent key speakers who will be joining us in 2 weeks’ time. The future …

Biopolis – Asia’s Premier Biomedical Hub

mildred Uncategorised Leave a Comment

  As the lead government agency responsible for the development of industrial infrastructure to support and catalyse the growth of industries and enterprises in Singapore, JTC has pioneered and developed innovative infrastructure solutions to meet the unique needs of the biomedical industry. One of these is Biopolis @ one-north, a world-class, purpose-built biomedical research and development hub. With 13 buildings …

Rare Disease Day – The Fight Against Rare Diseases

mildred Uncategorised Leave a Comment

First launched by EURORDIS and its Council of National Alliances in 2008, Rare Disease Day is now in its 9th year and is recognized in over 80 countries on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on …

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

Maximizing injectables production: Enabling consistent supply

mildred Uncategorised Leave a Comment

One of the most significant trends today in our industry is the enormous growth of the injectable market. Injectables are becoming the single largest driver of the pharma/biotech market and offer tremendous opportunity. However, bringing an injectable to market is no small feat. Staying competitive, once in the market, can be just as challenging. Market and regulatory requirements regarding safety …

Meeting the inherent challenges of complex drug substances

mildred Uncategorised Leave a Comment

Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages. A careful, systematic approach to identifying where and why these roadblocks …

Moving towards genomics driven precision medicine in Asia

Emily Event News Leave a Comment

Emerging technologies are disrupting every industry, with no exception to  biomedical industry in Asia. Early stage biotech companies including Strand Lifesciences are tapping onto this latest trend to provide innovative tools and strategies to improve how stakeholders work in the industry. Vijay Chandru, Executive Chairman of Strand Lifescience joined us at the 14th BioPharma India, Mumbai on 15-16 November 2016. In case …

Sustaining innovation-based biotech in the home of generics

Emily Event News Leave a Comment

India is probably one of the world’s most successful generics markets. Despite all the scandals related to quality of the generics drugs supplied to developed market, the country still remains the home of low cost, high quality generics production. We interviewed Dr C.N. Ramchand, founder of several innovative companies including Saksin Lifesciences and MagGenome to seek his rationale of going …

Regaining the confidence of Chinese biomanufacturing industry

Emily Event News Leave a Comment

Similar to other developing countries, the quality of Chinese bioproduction is often questioned by international markets due to various outbreak of scandals related to breach of quality protocols in production process. We invited Dr Amy Que, Vice President of Quality Control of Innovent Biologics, one of the leading innovation-driven biotech companies emphasizing on quality production to speak at the 10th BioPharma …